Speakers

Take a look at the esteemed speaker faculty for the 15th World Clinical Biomarkers & CDx Summit.

CB & CDx Ambassadors
Payers, Notified Bodies, & Patient Advocates
Pharmaceutical Leaders
Innovative Biotech
Research & Healthcare Institutes
Diagnostic & Solution Providers

CB & CDx Ambassadors

Mark Gustavson

Senior Director & Global Head Computational Pathology Translational Science
AstraZeneca

Geoff Oxnard

Chief Medical Officer
BlossomHill Therapeutics

Sarah Hersey

VP PMBATS
Bristol Myers Squibb

Katia Bassett

Senior Director and Head, CDx Development, Translational Medicine
Genentech

Ben Withey

Director, Commercial Diagnostics, CDx Lead
Pfizer

Brian Lockhart

Global Head of Companion Diagnostics
Servier

Payers, Notified Bodies, & Patient Advocates

Sally Werner

Chief Executive Officer
Cancer Support Community
Nicole Sheahan

Nicole Sheahan

President
Global Colon Cancer Association

Gabriel Bien-Willner

Chief Medical Officer
Palmetto GBA
Anna Berkenblit

Anna Berkenblit

Chief Scientific & Medical Officer
Pancreatic Cancer Action Network

Anthony Kanavage

IVD Product Assessment Team Manager
TÜV SÜD

Kevin Liang

Vice President, Optum Evidence Engine
UnitedHealth Group

Pharmaceutical Leaders

Banu Sankaran

Head of Diagnostics Strategy & Development
Alexion Pharmaceuticals

Dishant Kalra

Head of Precision Medicine
Astellas Pharma

Cedric Dos Santos

Global Product Leader
AstraZeneca

Vasiliki Pelekanou

Senior Director - Digital Pathology, Oncology Precision Medicine Leader
Bayer

Kazuishi Kubota

Head Of Functional Excellence & Clinical Biomarker Oncology Department
Daiichi Sankyo

Andrea Renninger

Senior Director, Regulatory Affairs & Companion Diagnostics
Daiichi Sankyo

Ying Wu

Director & Head of Human Genetics
Eisai Co., Ltd.

Susanne Rhoades

Associate Vice President, Diagnostic Development
Eli Lilly

Dun Liang

Global Regulatory Affairs, Diagnostics
Eli Lilly & Co.

Zheng Feng

Director & Head of Clinical Genomics, Clinical Biomarker Technologies
EMD Serono

Anupam Talapatra

Director
Gilead Sciences

Tom Battersby

Executive Director, Biomarker-Research
Gilead Sciences

Andrea Belanger

Associate Director, Precision Medicine External Innovation
GlaxoSmithKline

Gabriele Allegri

Vice President, Global Commercial Precision Medicine
Johnson & Johnson

David Weingeist

Director
Johnson & Johnson

Renee Yura

Executive Director, Clinical Biomarkers
Moderna

Irina Leaf

Director - Therapeutic Area Biomarker, Disease Area & Global Health Lead
Novartis AG

Shelley Ann des Etages-Wong

Senior Director, Diagnostics PMO Lead
Pfizer

Jennifer Hamilton

Vice President & Head - Precision Medicine
Regeneron Pharmaceuticals

Brian Baker

Executive Director, Regulatory Affairs & In Vitro Diagnostics
Regeneron Pharmaceuticals

Gerard Sanderink

Vice President Laboratory Sciences
Sanofi

Cheng Yang

Digital Diagnostics Lead
Takeda Pharmaceutical

Silva Krause

Executive Director, Head of Biomarkers
Vertex Pharmaceuticals

Innovative Biotech

June Lu

Chief Scientific Officer
BeyondSpring Pharmaceuticals Inc.

John Rossi

Vice President - Translational Medicine
Capstan Therapeutics

Mike Kagey

Vice President, Translational Medicine
Leap Therapeutics
Zhen Su

Zhen Su

Chief Executive Officer
Marengo Therapeutics

Jorge DiMartino

Chief Medical Officer & Executive VP, Clinical & Translational Development
Plexium Inc.

Simon Beaulah

Senior Vice President, Healthcare & Head of US Operations
PrecisionLife Ltd.

Brenton Mar

Senior Vice President & Head of Clinical Development
Relay Therapeutics

Research & Healthcare Institutes

Sylvan Baca

Assistant Professor & Medical Oncologist
Dana-Farber / Harvard Cancer Center

Mark Stewart

Senior Analyst & Vice President - Science Policy
Friends of Cancer Research

Pedram Razavi MD, PhD

Director, Liquid Biopsy and Cancer Genomics, MSK Biomarker Development Program
Memorial Sloan Kettering Cancer Center

Viktor Adalsteinsson

Director, Gerstner Center for Cancer Diagnostics
The Broad Institute of MIT & Harvard

Diagnostic & Solution Providers

Verena Aumiller

Vice President - Scientific Programs
Aignostics

Katarina Wikstrom

Global Vice President of Product Development
Almac

Lydia Tsai

Director - Business Development & Companion Diagnostics
Bio-Techne Corporation

Colin McDowell

Senior Manager - Business Development
Biodesix

Yiming Guo

scientist
Burning Rock Biotech

Gulfem Guler

Vice President, Translational Research
Clear Note Health

Gary Potikyan

Chief Science Officer & Founder
EntroGen - Inc

Ali Kuraishy

Senior Director & Head of Clinical Business Development
Illumina, Inc.

Siraj Ali

Global Vice President, Translation Medicine
Lunit

J Carl Barrett

Chief Scientific Officer
Precede Biosciences

Leila Luheshi

Vice President - Pharma Partnering
Sysmex Precision Medicine

David Chi

Director, Product Management, Oncology
Thermo Fisher Scientific Inc
2
Explore the Agenda

Hear the latest translational, clinical and post-approval breakthroughs and gain exclusive insights into precision medicine innovations during our packed agenda, interactive roundtables, and new drug-diagnostic partnerships panel discussions

View Presentations & Speakers
3
Partner With Us

Position yourself alongside other leading IVD and CDx solution providers to ensure your brand is at the heart of precision medicines deals and collaborations

Explore Sponsorship Options
1
Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning a range of precision therapy modalities and indications, and make critical connections during our dedicated networking sessions

Register Now